Loading clinical trials...
Loading clinical trials...
The aim of this project: 1. Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab. 2. Medium-term follow up (6 months) of the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT07539675 · Primary Angle-Closure Glaucoma
NCT06289491 · Glaucoma, Glaucoma, Open-Angle
NCT07496957 · GLAUCOMA 1, OPEN ANGLE, D (Disorder)
NCT04354545 · Glaucoma, Ocular Surface Disease
NCT07455786 · Glaucoma
Sint-Raphaël hospital
Leuven, Vlaams-Brabant
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions